Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
BMJ Case Rep ; 17(2)2024 Feb 27.
Article En | MEDLINE | ID: mdl-38417946

Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare immune-mediated movement disorder occurring as a paraneoplastic manifestation of neuroblastic tumours (NTs), especially neuroblastoma in infancy. Ganglioneuroma (GN), the benign tumour in the spectrum, is rarely associated with OMAS. We report the case of a child in her second year of life presenting with acute onset of progressive paraplegia and OMAS. MRI showed diffuse and infiltrating left paraspinal mass from T3-T9 levels with differentials of neuroblastoma or ganglioneuroblastoma. Histopathological and immunohistochemistry examination of the excised tumour showed maturing GN. The OMAS was managed with intravenous immunoglobulin and steroids. In the 6-month follow-up, the child has a residual motor weakness with myelomalacia in neuroimaging. The case report substantiates the occurrence of OMAS as paraneoplastic manifestation in NTs, including benign, in children younger than 2 years with a female predilection.


Ganglioneuroma , Neuroblastoma , Opsoclonus-Myoclonus Syndrome , Child , Humans , Female , Opsoclonus-Myoclonus Syndrome/complications , Opsoclonus-Myoclonus Syndrome/diagnosis , Ganglioneuroma/complications , Ganglioneuroma/diagnosis , Neuroblastoma/diagnosis , Ataxia/complications , Movement
...